Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Aevi Lead Candidate Misses Primary Endpoint in Mid-Stage Study

Aevi Genomic Medicine said today that its lead candidate AEVI-001 has failed the Phase II SAGA trial assessing the ...

Forward this item to a colleague:


(Separate multiple addresses by commas)